NuMedii, Inc. Announces New Partnership To Discover New Treatments For Idiopathic Pulmonary Fibrosis

NuMedii, Inc announced the formation of a strategic partnership with Three Lakes Partners, LLC, to d...

Antibe Therapeutics Approved to Conduct Phase II Trial for ATB-346

Antibe Therapeutics has announced that it has received approval from Health Canada to initiate a Pha...

Jazz Pharma and ImmunoGen announce strategic collaboration to develop Antibody-drug conjugate products

Jazz Pharmaceuticals plc and ImmunoGen, Inc. announced that the companies have entered into a collab...

Thermo Fisher Completes Acquisition of Patheon to expand biopharma services

Thermo Fisher Scientific has completed its acquisition of Patheon, a leading contract development an...

Adamas Announces FDA Approval of GOCOVRI as First and Only Medication for the Treatment of Dyskinesia in Parkinson's Disease Patients

Adamas Pharmaceuticals, Inc. announced that the U.S. FDA has approved GOCOVRI extended release capsu...

  • NuMedii, Inc. Announces New Partnership To Discover New Treatments For Idiopathic Pulmonary Fibrosis

  • Antibe Therapeutics Approved to Conduct Phase II Trial for ATB-346

  • Jazz Pharma and ImmunoGen announce strategic collaboration to develop Antibody-drug conjugate products

  • Thermo Fisher Completes Acquisition of Patheon to expand biopharma services

  • Adamas Announces FDA Approval of GOCOVRI as First and Only Medication for the Treatment of Dyskinesia in Parkinson's Disease Patients

Projects

The Emmes Corporation Wins $70 Million Contract for Pediatric Research

The Emmes Corporation announced that it was awarded a contract from the National Institutes of Health to support pediatric clinical trials sponsored by the National Institute of Child Health and Human

Read more »
NuMedii, Inc. Announces New Partnership To Discover New Treatments For Idiopathic Pulmonary Fibrosis

NuMedii, Inc announced the formation of a strategic partnership with Three Lakes Partners, LLC, to discover and advance new treatments for idiopathic pulmonary fibrosis (IPF) based on NuMedii’s

Read more »
Amri Announces Strategic Alliance To Advance Mass Spectrometry Capabilities For Drug Discovery

AMRI , a global contract research and manufacturing organization working to improve patient outcomes and quality of life, has entered an alliance with Bruker Daltonics and HighRes Biosolutions to deve

Read more »

News

Liquid Biopsy Tumor Heterogeneity Test Predicts Resistance to Targeted Therapy In Metastatic Prostate Cancer Patients

Epic Sciences along with researchers at the MD Anderson Cancer Center (MDA) have recently published their findings on androgen receptor (AR) protein expression in circulating tumor cells (CTCs) in pat

Read more »
Arctic™ Sperm Cryopreservation Medium introduced by Irvine Scientific

Irvine Scientific, a world leader in the development and manufacture of cell culture media and Assisted Reproductive Technologies (ART), today announced the introduction of Arctic™ Sperm Cryopreserv

Read more »
Marken Acquires Touchdown International Ltd in Taiwan

Marken announced today the acquisition of Touchdown International Ltd, a privately held specialty logistics company in Taiwan, for an undisclosed sum. Touchdown is 100% dedicated to the life sciences

Read more »

Market Reports

Catalent To Acquire Cook Pharmica For $950 Million

Catalent, Inc. the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, today announced it has reached an agreement t

Read more »
NuVasive Announces Acquisition Of Vertera Spine

NuVasive, Inc. , a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the acquisition of Vertera Spine,

Read more »
3SBio Accelerates Expansion of its Global Biologics Platform by Acquiring the Canadian Biomanufacturing Business of Therapure

3SBio Inc. , a leading Chinese biopharmaceutical company, is pleased to announce today that it has entered into a Shareholder Agreement with CPE Funds, pursuant to which a Joint Venture (the "JV") sha

Read more »

Press Releases

Swift Launches Accel-Amplicon Custom NGS Panels, Accelerating Variant Discovery in Challenging Biological Samples

Swift Biosciences, a leading provider of innovative library prep solutions for next-generation sequencing announced the launch of its Accel-Amplicon™ Custom NGS Panels. These new panels offer a targ

Read more »
Trelegy Ellipta approved as single inhaler triple therapy for the treatment of appropriate patients with COPD in the US

GlaxoSmithKline plc and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved once-daily, single inhaler triple therapy fluticasone furoate/umeclidi

Read more »
Kaneka’s CDMO Eurogentec to build new biologics manufacturing plant in Belgium

Belgium-based CDMO Kaneka Eurogentec, a unit of Japanese chemical giant Kaneka, will build a new biologics manufacturing facility as part of the company’s expansion into large-scale production of bi

Read more »

Featured Events

Subscribe To Our Newsletter

Security Q:How many eyes has a typical person? (ex: 1)
Name:
Email: